2024. ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER. Western European Journal of Medicine and Medical Science. 2, 6 (Jun. 2024), 11–20.